GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from Flagship-Founded Vesalius
Vesalius Therapeutics’ AI-based technology finds novel targets and intervention points for subgroups of patients within a common disease. A small molecule that Vesalius has been developing for a novel Parkinson’s disease target is now headed to GSK, which has licensed global rights.
Revolutionizing Breast Cancer Survivorship Care: Early Detection and Prevention of Lymphedema
Our goal should be to make lymphedema a preventable aspect of cancer survivorship or at a minimum, manageable, rather than a debilitating aftereffect that diminishes patients' quality of life.
7 States Passed Abortion Rights Ballot Measures. But Changes Won’t be Like a “Light Switch,” Experts Say
In the 2024 election, seven out of 10 states passed ballot measures protecting abortion rights. But the effects won't be seen immediately, experts say.
Don’t Erode Medical Device Trust with Right to Repair
Right to repair would undermine the FDA’s regulations and introduce unnecessary risk into the healthcare industry, threatening the high-quality care that doctors provide patients.
Bundling Boomer Housing with On-site Primary Care and Wellness-Focused Living: It Just Makes Sense
Providing proactive and preventive health-focused living among younger, less affluent senior populations -- and extending this into value-based care -- just makes sense.